logo
Neanderthals ‘loved to eat maggots'

Neanderthals ‘loved to eat maggots'

Yahoo6 days ago
Neanderthals loved eating maggots and were not the total carnivores people often believed they were, a study has found.
It has long been believed that Neanderthals, the ancient cousin species of our human ancestors, ate almost nothing but meat in a similar way to lions or wolves.
But a study has found this to be incorrect and proves that Neanderthals instead dined largely on maggot-riddled meat.
The meat from successful hunts would be stashed and inevitably left to fester but the maggots which took root were also likely a staple of their diet, new analysis has found.
Previous studies of Neanderthal remains have shown they had the same chemicals in their bones as hypercarnivore predators, which is indicative of a purely carnivorous diet.
This, combined with the knowledge that Neanderthals hunted animals such as mammoths, bison, deer and reindeer, led to the widespread assumption that Neanderthals ate almost nothing but meat.
But Dr Melanie Beasley, an anthropologist at Purdue University in Indiana, US, suspected this to be incorrect and studied maggots feasting on human remains to see if they could account for the chemical signature which implies a carnivore diet.
Analysis found that when a carcass rots, the muscles themselves become only marginally enriched with the specific form of nitrogen found in Neanderthal remains.
But when maggots eat the flesh and themselves are consumed, these can be up to 43 per cent richer in the nitrogen which scientists have previously thought proved carnivore behaviour.
'We suggest that the nitrogen values are inflated, perhaps substantially so, because these dedicated hunters of large mammals would have stored or cached portions of their kills for later use to compensate for unpredictable returns,' the study team wrote.
'Back-up reserves of animal foods, either as packets of processed meat and fat, or as partial or complete carcasses, would have been placed in expedient above-ground rock or log cairns, suspended from tree branches or placed on above-ground racks or stages, immersed in ponds and swamps, or buried in below-ground pits.
'Such reserves, whether fresh, dried, or smoked, readily attracted flies while they were being processed, and, over the use life of the reserve, the contents almost inevitably began to putrefy and become infested with maggots.'
This slowly rotting meat which was being devoured by maggots could have been eaten weeks, months, or even years after it was first hunted, the scientists concluded.
To gauge what nutrients maggots contained the scientists buried 34 human bodies donated for research at the Body Farm facility of the University of Tennessee.
After two years, the maggots were studied and it was found that they were the likely reason for the high nitrogen content in Neanderthal remains that led to the assumption they were almost exclusively carnivores.
Another factor in the scientists' conclusion about the Neanderthal diet is that it is impossible for a human body to survive for very long if it is consuming more than 300g of protein a day. Prolonged exposure to a diet beyond this, which is around 1,200 calories of pure protein, can lead to 'rabbit starvation' in which the body begins to shut down.
This biological incompatibility with the protein-heavy diet and the maggot nitrogen finding are strong evidence that the Neanderthal was not a hypercarnivore like lions, the scientists say.
'A lion, on average, consumes anywhere from double to four-and-a-half times more protein per kg of body weight than the absolute maximum a Late Pleistocene hominin would be capable of tolerating,' the scientists wrote.
The Neanderthal diet was likely to have included tongue, ribs, briskets, entrails, kidneys and other internal organs, and probably also the brain, the scientists believe.
'Fascination' of hypercarnivore image
But Dr Beasley believes Neanderthals 'often ate these fat-rich tissues in a tainted or putrefied state together with their almost inevitable infestation of living and dead maggots'.
'It seems very likely that Late Pleistocene hominins would often have found themselves consuming animal foods from tainted or putrefied reserves laced with living and dead maggots,' she told The Telegraph.
'I think for a long time the hypercarnivore narrative about Neanderthals has been wrong but that image adds to their exceptionalism and fascination, so that narrative has persisted.
'Hominins ate meat regularly starting with Homo erectus, but they ate a diversity of other foods too.
'We are just saying that we need to consider those other dietary inputs like the inevitable stored foods laced with fatty maggots that would have been nutritionally beneficial.'
The study is published in Science Advances.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Option Care Health, Inc. (OPCH): A Bull Case Theory
Option Care Health, Inc. (OPCH): A Bull Case Theory

Yahoo

time5 minutes ago

  • Yahoo

Option Care Health, Inc. (OPCH): A Bull Case Theory

We came across a bullish thesis on Option Care Health, Inc. on Brian's Substack by Brian Flasker. In this article, we will summarize the bulls' thesis on OPCH. Option Care Health, Inc.'s share was trading at $29.35 as of July 31st. OPCH's trailing and forward P/E were 23.29 and 19.65, respectively according to Yahoo Finance. A home infusion nurse in full PPE gown delivering treatments to a patient in their own home. Option Care Health (OPCH) has evolved into the dominant independent provider of home and alternate site infusion services in the U.S., originating from Madison Dearborn Partners' 2015 acquisition of Walgreens Infusion Services. The 2019 reverse merger with BioScrip and full divestiture by Walgreens and MDP by 2023 paved the way for OPCH to operate with full independence. Led by CEO John Rademacher and CFO Michael Shapiro, both with substantial equity stakes, OPCH has built a national infrastructure of 91 pharmacies and 99 infusion suites, covering 96% of the U.S. population. The company's integrated model provides cost-effective, high-quality infusion therapies in outpatient and home settings, capitalizing on a healthcare trend shifting treatments away from costly hospitals. This platform serves over 1,400 contracts with 800+ partners, including all top 10 national insurers. Acute therapies, though operationally complex, act as a competitive wedge, while chronic therapies anchor long-term recurring revenues. OPCH's mix—75% chronic, 25% acute—combined with a focus on generics and biosimilars, ensures resilience against pricing volatility. With its Advanced Practitioner (AP) model, OPCH is pushing clinical boundaries, managing more complex therapies in lower-cost settings and enhancing utilization of its already-built infrastructure. Only ~50% of its infusion suite capacity is currently utilized, leaving ample runway for capital-light growth. Despite industry concerns like drug pricing reforms and labor shortages, OPCH's embedded relationships, clinical capabilities, and scalable model offer strong visibility into cash flow and earnings. Trading at ~15.4x 2025 owner earnings with a 17.4% expected IRR, OPCH represents a high-quality compounder with an entrenched moat and significant upside. Previously, we covered a bullish thesis on Chemed Corporation by 310 Value in April 2025, which highlighted the durability of its earnings, temporary volatility in its subsidiaries, and disciplined share repurchases. The company's stock price has depreciated by approximately 29% since our coverage. This is because temporary segment headwinds persisted longer than expected. The thesis still stands as Chemed's core fundamentals remain intact. Brian Flasker shares a similar view but emphasizes OPCH's capital-light model and payer-aligned infrastructure. Option Care Health, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held OPCH at the end of the first quarter, which was 40 in the previous quarter. While we acknowledge the potential of OPCH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Canada Wildfires Worsen Air Quality Across Midwest, Northeast US
Canada Wildfires Worsen Air Quality Across Midwest, Northeast US

Bloomberg

time5 hours ago

  • Bloomberg

Canada Wildfires Worsen Air Quality Across Midwest, Northeast US

Smoke and grit from hundreds of forest fires have spread across large parts of Canada and the northern US, sending air quality across the Midwest and northeast US and Toronto to unhealthy levels. Air quality deteriorated to moderate in Chicago early Sunday with some areas unhealthy for sensitive groups, and to unhealthy in Milwaukee and downtown Toronto, Canada's largest city, according to Alerts were raised across Canada from the Northwest Territories to Quebec, as well as in 10 US states from Minnesota to Maine, including Upstate and western New York.

HHS: How we're fixing the organ transplant system that betrayed America
HHS: How we're fixing the organ transplant system that betrayed America

CNN

time7 hours ago

  • CNN

HHS: How we're fixing the organ transplant system that betrayed America

EDITOR'S NOTE: Thomas Engels is the administrator of the Health Resources and Services Administration at the US Department of Health and Human Services. Organ donation can be a profound last gift of life. I think about the future my grandson will inherit, especially when it comes to something as urgent and deeply personal as organ donation or transplant. If he or someone he loves needs an organ transplant, I want him to know the system is safe, fair and worthy of his trust. Sadly, our US Department of Health and Human Services investigation of the organ transplant system has revealed everyone's worst nightmare: a systemic disregard for the sanctity of life. We found numerous cases of medical providers starting the organ donation process on living patients. In response, we have threatened to shut down a large organ procurement organization unless it implements our corrective action requirements. We have also imposed strict reporting protocols for the organ transplant system and required that families and hospitals receive clear, complete information about the donation process. How did the organ transplant system fail to protect some of our most vulnerable Americans? It operated behind closed doors for decades, dominated by a single private contractor. Too many patients waited for answers that never came, and families whose loved ones' organs were pursued while still alive were left with nowhere to turn when such atrocities occurred. Only a sick system prioritizes profit over patients. That ended thanks to the leadership of President Donald Trump and HHS Secretary Robert F. Kennedy Jr. At the Health Resources and Services Administration (HRSA), we are undertaking a sweeping overhaul of the Organ Procurement and Transplantation Network (OPTN), the entity legally responsible for managing the organ waitlist and allocation nationwide. Our reforms are rooted in two fundamental truths: Patient safety is not optional, and every life is sacred. For far too long, patients, hospital staff or grieving families were forced to report serious safety concerns and misconduct to the very contractor managing the system. This left families unheard, frustrated or even silenced. That era is over. Now, under our new reforms, those concerns can come directly to the regulator HRSA. We brought federal oversight into the heart of the process, making it clear there will be no compromise on safety and accountability. We've also proposed new data requirements for organ procurement organizations (OPOs), requiring full documentation of every step in the donation process, from contact with hospitals to interactions with donor families. These reforms aren't just about performance tracking. They're about restoring safety and dignity to a system that lost sight of both. And when horrifying failures come to light, like the shocking case in Kentucky in which organ procurement was nearly performed on a patient who showed signs of life, we act immediately. For the first time, HRSA issued a corrective action plan to an OPO, and we will not hesitate to do it again. No American should ever have to wonder whether their life will be treated with reverence at the hospital. The systemic failures weren't just operational — they were structural. For nearly 40 years, OPTN was governed by a single private entity: the United Network for Organ Sharing (UNOS). We ended a monopoly that suppressed innovation, enabled conflicts of interest and delayed reform. HRSA conducted a historic national election to establish an independent OPTN Board of Directors. This new board includes transplant surgeons, living donors, organ recipients and advocates, bringing a range of expertise and experience to the forefront of reform. We are also modernizing the transplant system by expanding the pool of best-in-class vendors to expand the capacity and performance of the system. With bipartisan support, HRSA now has the authority to directly collect OPTN registration fees from transplant hospitals, helping sustain long-term reforms and reduce reliance on any single contractor. Our work is informed by conversations with transplant surgeons, patients, donor families, advocates and hospital staff. These voices have made one thing abundantly clear: Change cannot wait. Secretary Kennedy has demanded accountability across HHS, and President Trump has shown unwavering commitment to ending complacency in systems that cost lives. The old system operated behind closed doors. We opened them up. We are building a system that is ethical, transparent and centered on the sacred sanctity of life. There is more work to do, but we are making progress quickly, just like the rest of the Trump administration. We will not rest until every registered organ donor, patient and family have confidence in our nation's transplant system. Because that's what Americans deserve and what every life demands.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store